French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  Favrod, Jerome ^a,b   Rexhaj, Shyhrete ^a,b   Ferrari, Pascale ^a,b   Bardy, Sabrina ^b   Hayoz, Claude ^c   Morandi, Stéphane ^b   Bonsack, Charles ^b   Giuliani, Fabienne ^b  

^a UNIVERSITY OF APPLIED SCIENCES WESTERN SWITZERLAND   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Fondation HorizonSud ^*  (Switzerland)

Author keywords

Delusion; Hallucination; PANSS; PSYRATS; Reliability; Schizophrenia; Validity

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTPATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOMETRY; PSYCHOTIC SYMPTOM RATING SCALE; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; AUDITORY HALLUCINATION; CASE MANAGEMENT; CLINICAL ASSESSMENT TOOL; CONVERGENT VALIDITY; DELUSION; FACTORIAL ANALYSIS; ICD-10; INTERRATER RELIABILITY; PSYCHOSIS; SAMPLE SIZE;

ADULT; DELUSIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRANCE; HALLUCINATIONS; HUMANS; MALE; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SWITZERLAND;

EID: 84866722256     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-161     Document Type: Article

References (31)

1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261-276.
2. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS) 1984, Iowa City: The University of Iowa.
3. Overall JE. The Brief Psychiatric Ratin Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988, 24:97-99.
4. Steel C, Garety PA, Freeman D, Craig E, Kuipers E, Bebbington P, Fowler D, Dunn G. The multidimensional measurement of the positive symptoms of psychosis. Int J Methods Psychiatr Res 2007, 16(2):88-96. 10.1002/mpr.203, 17623388.
5. Mizrahi R, Kiang M, Mamo DC, Arenovich T, Bagby RM, Zipursky RB, Kapur S. The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders. Schizophr Res 2006, 88(1-3):111-118.
6. Miller LJ. Qualitative changes in hallucinations. Am J Psychiatry 1996, 153(2):265-267.
7. Schneider SD, Jelinek L, Lincoln TM, Moritz S. What happened to the voices? A fine-grained analysis of how hallucinations and delusions change under psychiatric treatment. Psychiatry Res 2011, 188(1):13-17. 10.1016/j.psychres.2010.12.013, 21215461.
8. Moritz S, Jelinek L. Further evidence for the efficacy of association splitting as a self-help technique for reducing obsessive thoughts. Depress Anxiety 2011, 28(7):574-581. 10.1002/da.20843, 21681869.
9. Favrod J, Maire A, Bardy S, Pernier S, Bonsack C. Improving insight into delusions: a pilot study of metacognitive training for patients with schizophrenia. J Adv Nurs 2011, 67(2):401-407. 10.1111/j.1365-2648.2010.05470.x, 20955184.
10. Khazaal Y, Favrod J, Azoulay S, Finot SC, Bernabotto M, Raffard S, Libbrecht J, Dieben K, Levoyer D, Pomini V. "Michael's Game," a card game for the treatment of psychotic symptoms. Patient Educ Couns 2011, 83(2):210-216. 10.1016/j.pec.2010.05.017, 20646892.
11. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med 1999, 29(4):879-889. 10.1017/S0033291799008661, 10473315.
12. Drake R, Haddock G, Tarrier N, Bentall R, Lewis S. The Psychotic Symptom Rating Scales (PSYRATS): Their usefulness and properties in first episode psychosis. Schizophr Res 2007, 89(1-3):119-122.
13. Kronmuller KT, von Bock A, Grupe S, Buche L, Gentner NC, Ruckl S, Marx J, Joest K, Kaiser S, Vedder H, et al. Psychometric evaluation of the Psychotic Symptom Rating Scales. Compr Psychiatry 2011, 52(1):102-108. 10.1016/j.comppsych.2010.04.014, 21220071.
14. Hatton C, Haddock G, Taylor JL, Coldwell J, Crossley R, Peckham N. The reliability and validity of general psychotic rating scales with people with mild and moderate intellectual disabilities: an empirical investigation. J Intellect Disabil Res 2005, 49(Pt 7):490-500.
15. Gonzalez JC, Sanjuan J, Canete C, Echanove MJ, Leal C. Evaluation of auditory hallucinations: the PSYRATS scale. Actas Esp Psiquiatr 2003, 31(1):10-17.
16. Durham RC, Guthrie M, Morton RV, Reid DA, Treliving LR, Fowler D, Macdonald RR. Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up. Br J Psychiatry 2003, 182:303-311. 10.1192/bjp.182.4.303, 12668405.
17. Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, Siddle R, Drake R, Everitt J, Leadley K, et al. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry Suppl 2002, 43:s91-97.
18. Treatment of schizophrenia 1999 The expert consensus guideline series. J Clin Psychiatry 1999, 60(Suppl 11):3-80. Treatment of schizophrenia 1999.
19. Wykes T, Hayward P, Thomas N, Green N, Surguladze S, Fannon D, Landau S. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophr Res 2005, 77:201-210. 10.1016/j.schres.2005.03.013, 15885983.
20. Fisher DJ, Grant B, Smith DM, Borracci G, Labelle A, Knott VJ. Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified 'optimal' multi-feature paradigm. Int J Psychophysiol 2011, 81(3):245-251. 10.1016/j.ijpsycho.2011.06.018, 21749905.
21. Fisher DJ, Labelle A, Knott VJ. Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness. Schizophr Res 2012, 139(1-3):237-245.
22. Freeman D, Garety PA, Fowler D, Kuipers E, Bebbington PE, Dunn G. Why do people with delusions fail to choose more realistic explanations for their experiences? An empirical investigation. J Consult Clin Psychol 2004, 72(4):671-680.
23. Favrod J, Bardy Linder S, Pernier S, Mouron D, Schwyn C, Bonsack C, Pomini V. Entraînement des habiletés métacognitives avec des personnes atteintes de schizophrénie. TCC et neurosciences 2009, 103-114. Issy-les-Moulineaux: Elsevier Masson SAS, Cottraux J.
24. Favrod J, Ferrari P. Efficacy of metacognitive trainingto reduce delusions: arandomized clinical trial. Research protocol 2009, 25. Swiss National Science Fundation.
25. Schwyn C. Le monitoring de la source, vers une compréhension des hallucinations auditives persistantes. 2007, 112. Lausanne: Master thesis: Université de Lausanne, Faculté des sciences sociales et politique, Institut de psychologie.
26. Guelfi JD. The PANSS (Positive And Negative Symptom) Scale. Encéphale 1997, 23(Spec No 2):35-38.
27. Lancon C, Auquier P, Llorca PM, Martinez JL, Bougerol T, Scotto JC. Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients. Encéphale 1997, 23(1):1-9.
28. Chang JS, Yi JS, Ahn YM, Kim JH, Kim YS. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia. Aust N Z J Psychiatry 2009, 43(3):244-251. 10.1080/00048670802653299, 19221913.
29. Nayani TH, David AS. The auditory hallucination: a phenomenological survey. Psychol Med 1996, 26(1):177-189. 10.1017/S003329170003381X, 8643757.
30. Moritz S, Favrod J, Andreou C, Morrison AP, Bohn F, Veckenstedt R, Tonn P, Karow A. Beyond the Usual Suspects: Positive Attitudes Towards Positive Symptoms Is Associated With Medication Noncompliance in Psychosis. Schizophr Bull 2012, .
31. Favrod J, Grasset F, Spreng S, Grossenbacher B, Hodé Y. Benevolent voices are not so kind: the functional significance of auditory hallucinations. Psychopathology 2004, 37(6):304-308. 10.1159/000082269, 15564791.